Talk:HPV-positive oropharyngeal cancer

where is this mentioned in citation #50?

By 2007, in the US, incidence of general OPC, including non-HPV associated, is 1.9 per 100,000 all-sexes/year.Whereismylunch (talk) 07:49, 11 December 2014 (UTC)

Bibliography

Is everything listed in the bibliography used in the text? I trimmed these as they do not appear to be used.[1] Doc James (talk · contribs · email) 17:16, 19 September 2017 (UTC)

We should not be using primary sources such as these. Doc James (talk · contribs · email) 20:33, 21 September 2017 (UTC)

Yes they are used and deleting them created a whole lot of citations not pointing anywhere so I restored them. We should discuss the question of primary sources more generally. Perhaps at project level? --Michael Goodyear (talk) 16:30, 4 December 2017 (UTC)

They should be replaced by high quality secondary sources. Doc James (talk · contribs · email) 16:32, 4 December 2017 (UTC)

Those were already in place - the primary sources were supplementary --Michael Goodyear ✐  ✉ 01:42, 28 June 2018 (UTC)

External links modified

Hello fellow Wikipedians,

I have just modified one external link on HPV-positive oropharyngeal cancer. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

• Added archive https://web.archive.org/web/20160303183818/http://www.oralcancerfoundation.org/hpv/pdf/Chaturvedi-2007.pdf to http://www.oralcancerfoundation.org/hpv/pdf/Chaturvedi-2007.pdf

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 5 June 2024).

• If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
• If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—InternetArchiveBot (Report bug) 14:57, 20 November 2017 (UTC)

not dead - url updated Michael Goodyear (talk) 16:25, 4 December 2017 (UTC)

Links to clinical trials mentioned

• "Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer (DART-HPV)". ClinicalTrials.gov. National Library of Medicine. 19 July 2017.}}
• "Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer (ADEPT) NCT01687413". ClinicalTrials.gov. National Library of Medicine. 2 February 2017.
• "Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer NCT01898494 E3311". ClinicalTrials.gov. National Library of Medicine. 11 July 2017.
• "Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS) NCT02215265". ClinicalTrials.gov. National Library of Medicine. 10 August 2017.
• "PATHOS: A Phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV)-positive oropharyngeal cancer". Centre for Trials Research. Cardiff University. Retrieved 10 August 2017.
• "RTOG 9003. A Phase III Randomized Study to Compare Twice Daily Hyperfractionation, Accelerated Hyperfractionation with a Split and Accelerated Fractionation with Concomitant Boost to Standard Fractionation Radiotherapy for Squamous Cell Carcinomas of the Head and Neck". RTOG. 6 November 2013. Retrieved 1 June 2017.
• "RTOG 9501. Phase III Intergroup Trial of Surgery Followed by (1) Radiotherapy vs. (2) Radiochemotherapy for Resectable High Risk Squamous Cell Carcinoma of the Head and Neck". RTOG. 6 November 2013. Retrieved 15 June 2017.
• "RTOG 0129. A Phase III Trial of Concurrent Radiation and Chemotherapy (Followed by Surgery for Residual Primary/N2-3 Nodal Disease) for Advanced Head and Neck Carcinomas". RTOG. 23 July 2014. Retrieved 1 June 2017.
• "Major Radiation Reduction for HPV+ Oropharyngeal Carcinoma NCT03323463". ClinicalTrials.gov. National Library of Medicine. 29 March 2018. Retrieved 1 July 2018.
• "The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer NCT01706939". ClinicalTrials.gov. National Library of Medicine. 3 April 2018. Retrieved 3 July 2018.
• "Quarterback 2 - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer NCT01706939". ClinicalTrials.gov. National Library of Medicine. 17 October 2017. Retrieved 3 July 2018.

• "Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer (RTOG 1016 )". ClinicalTrials.gov. National Library of Medicine. 19 May 2017. Retrieved 14 August 2018.

A Commons file used on this page has been nominated for deletion

The following Wikimedia Commons file used on this page has been nominated for deletion:

• Papilloma Virus (HPV) EM.jpg

Participate in the deletion discussion at the nomination page. —Community Tech bot (talk) 01:54, 9 January 2020 (UTC)

Merge with article on oral cancer

HPV+ oral cancers are a subset of all oral cancers. Much of this information applies to HPV- oral cancers. Initial tumor symptoms and signs and treatment are almost if not always identical for example. These articles should be merged 104.128.161.34 (talk) 05:43, 30 November 2023 (UTC)

The article is large and it will not be easy. Ruslik_Zero 20:45, 30 November 2023 (UTC)